EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD)

Alisa Ambrodji iD, Angélique Sadlon, Ursula Amstutz, Dennis Hoch, Martin D Berger, Sara Bastian iD, Steven M Offer iD, Carlo R Largiadèr iD

International Journal of Molecular Sciences · 11.07.2024 · 25 (14) · 7599

DOI: 10.3390/ijms25147599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.07.2024. Verfasst von Alisa Ambrodji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Inselspital, University Hospital of Bern, University of Bern, INO-F, 3010 Bern, Switzerland. Hauptthemen laut MEDLINE: Dihydrouracil Dehydrogenase (NADP), Genotype, Genotyping Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pre-treatment genotyping of four well-characterized toxicity risk-variants in the dihydropyrimidine dehydrogenase gene (DPYD) has been widely implemented in Europe to prevent serious adverse effects in cancer patients treated with fluoropyrimidines. Current genotyping practices are largely limited to selected commonly studied variants and are unable to determine phasing when more than one variant allele is detected. Recent evidence indicates that common DPYD variants modulate the functional impact of deleterious variants in a phase-dependent manner, where a cis- or a trans-configuration translates into different toxicity risks and dosing recommendations. DPYD is a large gene with 23 exons spanning nearly a mega-base of DNA, making it a challenging candidate for full-gene sequencing in the diagnostic setting. Herein, we present a time- and cost-efficient long-read sequencing approach for capturing the complete coding region of DPYD. We demonstrate that this method can reliably produce phased genotypes, overcoming a major limitation with current methods. This method was validated using 21 subjects, including two cancer patients, each of whom carried multiple DPYD variants. Genotype assignments showed complete concordance with conventional approaches. Furthermore, we demonstrate that the method is robust to technical challenges inherent in long-range sequencing of PCR products, including reference alignment bias and PCR chimerism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dihydrouracil Dehydrogenase (NADP)GenotypeGenotyping TechniquesHumansSequence Analysis, DNANeoplasmsHigh-Throughput Nucleotide SequencingPolymorphism, Single NucleotideAlleles

Stichwörter der Autor:innen

DPYDOxford Nanopore Technologies sequencingPCR chimeracompound heterozygousfluoropyrimidineshaplotypelong-range ampliconpharmacogenomicsrare variants

Substanzen

Dihydrouracil Dehydrogenase (NADP)

Autor:innen und Institutionen

  • Department of Clinical Chemistry, Inselspital, University Hospital of Bern, University of Bern, INO-F, 3010 Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
  • Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland.
  • Department of Medical Oncology, Cantonal Hospital Graubünden, 7000 Chur, Switzerland.
  • Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: Alisa Ambrodji, Sara Bastian, Steven M Offer, Carlo R Largiadèr

Förderung

  • NCI NIH HHS
  • Swiss National Science Foundation

Zitieren

APA

Ambrodji, A., Sadlon, A., Amstutz, U., Hoch, D., Berger, M. D., Bastian, S., Offer, S. M., & Largiadèr, C. R. (2024). Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). International Journal of Molecular Sciences, 25(14), 7599. https://doi.org/10.3390/ijms25147599

Vancouver

Ambrodji A, Sadlon A, Amstutz U, Hoch D, Berger MD, Bastian S, et al. Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). International Journal of Molecular Sciences. 2024;25(14):7599. doi:10.3390/ijms25147599

BibTeX
@article{Ambrodji2024,
  author = {Ambrodji, Alisa and Sadlon, Angélique and Amstutz, Ursula and Hoch, Dennis and Berger, Martin D and Bastian, Sara and Offer, Steven M and Largiadèr, Carlo R},
  title = {Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD)},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {14},
  pages = {7599},
  doi = {10.3390/ijms25147599}
}
Kostenlos starten →